Regulation of the hepatitis C virus genome replication by miR-199a*

Journal of Hepatology

Volumn 50, Issue 3, 2009, Pages 453-460

  Murakami, Yoshiki ^a   Aly, Hussein H ^a   Tajima, Atsushi ^b   Inoue, Ituro ^b   Shimotohno, Kunitada ^c,d  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

HCV; microRNA; Replicon cell; RISC; Viral replication

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MIR 199A; UNCLASSIFIED DRUG;

ALGORITHM; ANTIVIRAL ACTIVITY; ARTICLE; GENE CONTROL; GENE OVEREXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ALGORITHMS; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HEPACIVIRUS; HEPATOCYTES; HUMANS; LIVER; MICRORNAS; MOLECULAR SEQUENCE DATA; PLASMIDS; REPLICON; RNA, SMALL INTERFERING;

EID: 59349098653     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.06.010     Document Type: Article

References (29)

1. Wasley A., and Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20 (2000) 1-16
2. Foster G.R. Past, present, and future hepatitis C treatments. Semin Liver Dis 24 (2004) 97-104
3. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New Engl J Med 339 (1998) 1485-1492
4. Pillai R.S. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 11 (2005) 1753-1761
5. Zamore P.D., and Haley B. Ribo-gnome: the big world of small RNAs. Science 309 (2005) 1519-1524
6. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., and Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 12 (2002) 735-739
7. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., and Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309 (2005) 1577-1581
8. Randall G., Panis M., Cooper J.D., Tellinghuisen T.L., Sukhodolets K.E., Pfeffer S., et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 104 (2007) 12884-12889
9. Henry S.D., van der Wegen P., Metselaar H.J., Tilanus H.W., Scholte B.J., and van der Laan L.J. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 14 (2006) 485-493
10. Kapadia S.B., Brideau-Andersen A., and Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 100 (2003) 2014-2018
11. Wang Y., Kato N., Jazag A., Dharel N., Otsuka M., Taniguchi H., et al. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130 (2006) 883-892
12. Yokota T., Sakamoto N., Enomoto N., Tanabe Y., Miyagishi M., Maekawa S., et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4 (2003) 602-608
13. Murata T., Ohshima T., Yamaji M., Hosaka M., Miyanari Y., Hijikata M., et al. Suppression of hepatitis C virus replicon by TGF-beta. Virology 33 (2005) 407-417
14. Ishii N., Watashi K., Hishiki T., Goto K., Inoue D., Hijikata M., et al. Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol 80 (2006) 4510-4520
15. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
16. Aly H.H., Watashi K., Hijikata M., Kaneko H., Takada Y., Egawa H., et al. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 46 (2007) 26-36
17. Watashi K., Hijikata M., Hosaka M., Yamaji M., and Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38 (2003) 1282-1288
18. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 (2006) 2537-2545
19. Kato N., Ikeda M., Mizutani T., Sugiyama K., Noguchi M., Hirohashi S., et al. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res 87 (1996) 787-792
20. Ohshima T., and Shimotohno K. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem 278 (2003) 50833-50842
21. MacQuillan G.C., Mamotte C., Reed W.D., Jeffrey G.P., and Allan J.E. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. J Med Virol 70 (2003) 219-227
22. Hsu P.W., Lin L.Z., Hsu S.D., Hsu J.B., and Huang H.D. ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res 35 (2007) D381-D385
23. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 104 (2007) 19291-19296
24. Naganuma A., Nozaki A., Tanaka T., Sugiyama K., Takagi H., Mori M., et al. Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol 74 (2000) 8744-8750
25. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., and Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454 (2008) 780-783
26. Cullen B.R. Viruses and microRNAs. Nat Genet 38 (2006) S25-S30
27. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev 5 (2005) 215-229
28. Honda A., Arai Y., Hirota N., Sato T., Ikegaki J., Koizumi T., et al. Hepatitis C virus structural proteins induce liver cell injury in transgenic mice. J Med Virol 59 (1999) 281-289
29. Fillebeen C., Muckenthaler M., Andriopoulos B., Bisaillon M., Mounir Z., Hentze M.W., et al. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 47 (2007) 12-22